跳至主要内容
临床试验/KCT0003259
KCT0003259招募中未知

A 12 week, multi-center, randomized, double-blind, placebo-controlled clinical trial for the evaluation of the efficacy and safety of SKBE on atopic dermatitis in children

ifetree Biotech0 个研究点目标入组 80 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
招募中
发起方
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional Study

入排标准

年龄范围
2(Year) 至 12(Year)(—)
性别
All

入选标准

  • 1) Subjects who agree the particpation in the trial and submit informed and consent before the beginning of the trial.
  • 2) subjects over 2 years and under 12 years of age inclusive
  • 3) Subjects scored 20~50 from SCORing of Atopic Dermatitis

排除标准

  • 1) The patient who take the medicine that can affect the state of Atopic Dermatitis within recent 1 week.
  • 2) Subjects which in the opinion investigator could affect preclude evluation of response

研究者

发起方
ifetree Biotech

相似试验